Scheme 1:
Spinel ferrite/mesosilicalite and MCM-41 nanocomposite for curcumin–cisplatin bound nanotherapeutic effect against MCF-7, HeLa and HCT 116 cancer cell lines
Scheme 1: | Cancer Nanotechnology
Spinel ferrite/mesosilicalite and MCM-41 nanocomposite for curcumin–cisplatin bound nanotherapeutic effect against MCF-7, HeLa and HCT 116 cancer cell lines